Background: Scabies is a frequent cutaneous infection caused by the mite Sarcoptes scabiei in a 22 large number of mammals including humans. As the resistance of S. scabiei against several 23 chemical acaricides has been previously documented, the establishment of alternative and 24 effective control molecules is required. 25 Objectives: In this study, the potential acaricidal activity of beauvericin was assessed against 26 different life stages of S. scabiei var. suis and, in comparison with dimpylate and ivermectin, two 27 commercially available molecules used for the treatment of S. scabiei infection in animals and/or 28 humans. 29 Methods: In our in vitro model, developmental stages of S. scabiei have been placed in Petri 30 dishes filled with Columbia agar supplemented with pig serum and different concentrations of 31 the drugs. Moreover, the toxicity of beauvericin against cultured human fibroblast skin cells was 32 evaluated using an MTT proliferation assay 33 Results: Beauvericin showed higher activity against adults and eggs of S. scabiei when 34 compared to dimpylate and ivermectin. In addition, cell sensitivity assays demonstrated low 35 toxicity of beauvericin against primary human fibroblast skin cells.
Introduction 40
Scabies is a frequent cutaneous infection caused by the mite Sarcoptes scabiei in a large number 41 of mammals including human. 1 Human scabies was recently recognized as a neglected tropical 42 disease by the WHO, due to its high global prevalence estimated to be around 100-200 million 43 cases a year, 2 and high morbidity. 3 Although primary infection with S. scabiei is limited to 44 severe itching and allergic rash, secondary infections with bacteria such as group A 45 streptococcus or Staphylococcus aureus could lead to severe acute infectious complications and 46 even death, 4 hence the importance of early and efficient eradication of the mites. 5 There is a 47 limited number of drugs that could be used for the treatment of scabies. Furthermore, the 48 resistance to some of the drugs of S. scabiei is emerging, caused by re-infection or incorrect use 49 of acaricides, may lead to an excessive and random use of treatments posing threat to patient 50 health. 6 Less susceptible populations of S. scabiei may emerge from the repeated exposure to a 51 single type of acaricide. The resistance development may involve a mutation to the target site of 52 the acaricide molecule or an up-regulation for genes encoding for detoxification enzymes (Van 92 To assess the efficacy of drugs (including beauvericin) against S. scabiei motile stages 93 (larvae/nymphs and females), Petri dishes filled with Columbia agar supplemented with pig 94 serum have been used for bioassays. To prepare the medium, 42g of Columbia agar (Bio-Rad, 95 Marne-la-Coquette, France) were dissolved in 1L of distilled water. The solution was autoclaved 96 for 15 min at 121°C then cooled down in a water bath at 53°C. Blood samples were obtained 97 from pigs maintained in CRBM. Tubes of blood were centrifuged at 4500 rpm for 10 min at 4°C.
In vitro efficacy tests on mites and eggs

98
The resulting supernatant was designated serum. For the preparation of each Petri dish, one ml of 99 serum was added to 18 ml of Columbia agar medium at 53°C. Drugs to be tested were 100 incorporated into the medium following the method described by Brimer 11,12 with slight 101 modifications. The mycotoxin beauvericin and two acaricide drugs (dimpylate and ivermectin) 102 were tested with different concentrations. The absence of drug concentration was considered as To assess the efficacy of chemical products against S. scabiei eggs, 10 eggs were manually 114 isolated using a fine needle and placed in the middle of beauvericin, dimpylate, or ivermectin-supplemented agar plates under the dissecting stereomicroscope as described above. Petri dishes 116 were maintained at 37°C in an incubator for 5 days to promote egg development. Newly hatched 117 larvae were recorded and removed from the Petri dishes.
118
Five replications were performed in three biological replicates, making it a total of 150 motile 119 stages and 150 eggs observed for each treatment.
120
Primary fibroblast culture 121 Human skin biopsies from healthy volunteer patients were delivered to the laboratory in culture 122 medium (RPMI 1640: 450 ml, FBS: 50 ml, and penicillin-streptomycin solution x100: 1 ml).
123
Each biopsy was transferred into a sterile Petri dish and rinsed with PBS to eliminate blood and 124 debris. Two ml collagenase (Worthington™) were added to the medium before mincing the 125 tissue with a scalpel. After incubation at 37ºC for 1h, the digested tissue was transferred to a 126 15 ml conical tube and the Petri dish was rinsed twice with 2 ml of the medium and the liquid 127 was collected in the same tube and span down at 200g for 5 min at room temperature. The pellet 128 was washed twice with 3 ml of the medium to remove the collagenase, resuspended with 5 ml of 129 the same medium and transferred to T25 flask. Finally, the cells were cultured in a 37°C 130 humidified air incubator with 5% CO 2 . When there were sufficient cells, the latter were detached free media. After starvation, fibroblast cells were exposed to the drugs as described above. Four 140 hours prior to the end of the treatment, 10µl MTT dye (100 mg Thiazolyl Blue Tetrazolium   141 Bromide, Sigma Aldrich, 20 ml PBS) were added to the wells. In addition, 100 µl MTT stop 142 solution (12mM HCl, 0.05% isobutanol, 10% SDS) was added to cells before incubation at 37ºC 143 overnight. After 24h, the absorbance was measured at 550 nm on an ELISA plate reader. All 144 tests were carried out in triplicates of three biological replicates. between the molecules and the concentration being used was notable 1h post-exposure (Table 1) .
168
The efficacy of the molecules at different concentrations can be put into the following order 169 based on their chi-square value: beauvericin > ivermectin > dimpylate and ivermectin > 170 dimpylate > beauvericin against females and immature forms, respectively ( Table 1 ). The 171 survival capacity seemed to be different according to the developmental stage of the mites.
172
Dimpylate and ivermectin had higher efficacy on S. scabiei immature motile stages when 173 compared to females; whereas, beauvericin displayed a higher efficacy on females at all 174 concentrations ( Table 1) . 175 The activity of all three molecules against S. scabiei eggs was evaluated for 5 days. Results
176
obtained with beauvericin, dimpylate or ivermectin were significantly different from those in the 177 control group (Table 1) . Among all the molecules tested against the eggs of S. scabiei, 178 beauvericin demonstrated the best inhibition of hatching effect, when testing a concentration of 179 50 µM. The second-highest activity was recorded when treating eggs with the same 180 concentration of dimpylate. The lowest activity was recorded at a concentration of 0.5 µM of 181 dimpylate or ivermectin with no significant statistical difference compared to the negative 182 control ( Table 1) .
183
LT 50 values were different between treatment groups against the motile stages of S. scabiei 184 ( Table 1 ). The highest LT 50 values (5.6 and 4.7h) were observed with a concentration of 0.5 µM 185 of beauvericin and dimpylate against females and nymphs/larvae, respectively. The lowest LT 50 186 values (1.1 and 1 h) were observed with a concentration of 50 µM of dimpylate and ivermectin against females and nymphs/larvae, respectively. The median time for hatching of 50% of the 188 eggs was also recorded in this study (Table 1) . complexes with cations and increases the permeability of biological membranes. [24] [25] [26] Given the 228 non-similarity of its mode of action to that of the commonly used neuro inhibitors, a cross-229 resistance of S. scabiei mites against beauvericin is unlikely to happen.
230
The three drugs selected for the bioassays had a low LT 50 value, indicating a rapid effect on the 231 mites. For beauvericin and dimpylate, LT 50 values were related to the concentration of the 232 molecules (death occurred more rapidly among mites treated with higher concentrations).
233
The dose-response test recorded low LC 50 values indicating high efficacy of all drugs at killing S. 
